Published

Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse Prevention

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Addiction Biology
Date: 2026-03-01
Source: Crossref
DOI: 10.1111/adb.70111
PubMed: 41780506

Authors

Koutrouli Isis Rita Anzel Brejtr Vojtěch Schwendt Marek Witek Kacper Charalambous Chrysostomos Aleksič Kristýna Miniariková Nina Lhotková Eva Toman Martin Nikolič Marek Jurok Radek Cihlářová Petra Mazoch Vladimír Ryšánek Pavel Kuchař Martin Šíchová Klára Páleníček Tomáš

Watch author

Derived topics and classifications

psilocybin Anxiety Addiction Animal Study Adverse Events Clinical Trial

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1176/appi.ajp.20231063 10.1002/cpt.2487 10.1002/wps.20555 10.1097/yco.0000000000000467 10.1038/npp.2017.84 10.1016/j.jad.2023.01.108 10.1124/pharmrev.120.000056 10.31887/dcns.2019.21.2/dnutt 10.1016/j.medj.2024.01.005 10.1177/0269881116675512 10.1080/105504999305848 10.1177/0269881114565144

Indexed papers citing this DOI

Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse Prevention2026-03-01

Related papers

Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic EffectsClinicalTrials.gov · 2026-07-09 Psychedelic Assisted Psychotherapy (PAP): the Geneva University Hospital modelEmerging Trends in Drugs Addictions and Health · 2025-12-01 Psychedelics for the Treatment of Substance Use DisordersSUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · 2025-12-01 Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial.Addiction (Abingdon, England) · 2025-07-24 "I've learned that I'm open-minded to this possibility": A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke.Addiction science & clinical practice · 2025-07-21 Disentangling debate about therapeutic and recreational use of psychedelicsAddiction · 2024-12-15 Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.European addiction research · 2024-01-01 Classic and non-classic psychedelics for substance use disorder: A review of their historic, past and current researchAddiction Neuroscience · 2022-06-22